Rationale: Because the Berlin definition of acute respiratory distress syndrome (ARDS) has only moderate reliability, physicians disagree about the diagnosis of ARDS in some patients. Understanding the clinical differences between patients with agreement and disagreement about the diagnosis of ARDS may provide insight into the epidemiology and pathophysiology of this syndrome, and inform strategies to improve the reliability of ARDS diagnosis.
Although the clinical manifestations of acute respiratory distress syndrome (ARDS) were described over 50 years ago (1) , efforts to codify these findings into a set of valid and reliable diagnostic criteria have had more limited success (2, 3) . The current Berlin definition of ARDS has only moderate interrater reliability when applied to patients with respiratory failure (4) . In addition, only 45% of patients who met the Berlin ARDS definition were found to have the histopathological hallmarks of ARDS in an autopsy series (5) . The lack of a valid and reliable ARDS definition is often cited as a major reason for the underrecognition of ARDS in clinical practice and slow progress in advancing ARDS research (6) (7) (8) (9) .
Because the current Berlin ARDS definition has only moderate reliability, two critical-care-trained physicians reviewing the same group of patients with acute respiratory failure are likely to disagree about whether some of the patients have ARDS (4) . Little is known about the patients with disagreement among physicians about the diagnosis of ARDS, or how these patients differ from those with a consensus among physicians that ARDS has developed. Understanding the differences in clinical characteristics among patients with agreement and disagreement about the diagnosis of ARDS may provide new insight into ARDS epidemiology and pathophysiology, and also might suggest strategies for improving the reliability of diagnosis in practice. If patients with diagnostic disagreement have uniquely identifiable clinical characteristics, such patients could be targeted for further observation or evaluation before diagnosis. In contrast, if patients with disagreement lack unique characteristics, but rather have a more intermediate presentation, this would suggest that difficulty in dichotomizing patients along a continuous spectrum of ARDS manifestations is the major reason for disagreement. If the latter is the case, understanding which physiologic parameters (e.g., arterial oxygen tension/ pressure [Pa O 2 ]/fraction of inspired oxygen [FI O 2 ] ) or combinations are best aligned with this spectrum could help improve stratification of patients moving forward.
In this study, we sought to characterize patients with diagnostic disagreement about ARDS among critical-care-trained physicians and compare them with patients with a consensus that ARDS developed. We hypothesized that these groups would have distinct clinical characteristics at the time when ARDS was first suspected, and that available clinical data could help differentiate them from other patients with hypoxemic respiratory failure.
Methods Patient Cohort and ARDS Reviews
Consecutive patients were independently reviewed for the development of ARDS by two to four intensive-care-trained physicians if they were admitted between January and March 2016 or between October 2016 and June 2017, and had a Pa O 2 /FI O 2 , 300 while receiving invasive mechanical ventilation at a single tertiary-care center. Patients in the medical, surgical, cardiac, and trauma/burn intensive-care units were included. Thirteen clinicians (six pulmonary critical-care faculty and seven advanced pulmonary critical-care fellows) reviewed the patients for ARDS.
Clinicians retrospectively reviewed each patient's hospitalization records, including all chest imaging studies (chest X-rays and computed tomography scans), to determine whether ARDS developed during the first week of hospitalization according to the Berlin definition (2). They evaluated whether patients had specific ARDS risk factors using standard definitions (10) and considered all information available during the hospitalization, including a patient's evolution over time and response to therapy. Clinicians also identified the specific time when all ARDS criteria were met. Clinicians used a standardized ARDS evaluation tool to guide each review, which prompted them to determine whether a patient met each Berlin ARDS criterion, followed by an overall assessment of ARDS. Further details of the ARDS review process have been previously described (4) .
Rates of ARDS diagnosis across individual clinicians, agreement rates among clinicians, and clinician characteristics potentially associated with differing rates of ARDS diagnosis and agreement were evaluated. Overall variation in the diagnosis of ARDS attributable to clinicians, rather than to differences between patients, was also quantified. These analyses are further described in the online supplement. We used a multilevel modeling strategy to estimate each patient's probability of ARDS based on the results of physician reviews, and then categorized the patients as consensus-ARDS, disagreement, or no ARDS based on the probability derived from this model. Technical details of the modeling approach and sample code are described in the online supplement. This approach allowed us to account for differences in the total number of reviews performed for each patient and systematic differences between clinicians in their reviews. Patients with greater disagreement among clinicians had a more intermediate probability of ARDS in the model. Patients with greater agreement that ARDS developed had a higher estimated ARDS probability, whereas patients with agreement that ARDS did not develop had low probability. Patients with a probability of ARDS above 80% were defined as consensus-ARDS, patients with a probability of 20-80% were defined as disagreement, and patients with a probability below 20% were defined as no ARDS.
Clinical Characteristics and Outcome Variables
Baseline demographic information and selected comorbidities were collected for all patients. Physiologic data were extracted from the electronic health record during the first 24-hour period after ARDS onset for those suspected of developing ARDS by any physician, or during a randomly matched 24-hour period of mechanical ventilation for those without ARDS (matched based on mechanical ventilation day). The ARDS onset time was defined as the earliest time a clinician believed all ARDS criteria were met. Physiologic characteristics abstracted during the 24- (11) , highest measured plateau pressure, lowest quasi-static lung compliance, and highest estimated dead space fraction (12) . Because data can be incorrectly recorded in the electronic health record, outlier values were dropped if they were three standard deviations from the mean. Missing data on plateau pressure (9%), lung compliance (11%), and dead space fraction (8%) during the 24-hour window ORIGINAL RESEARCH were imputed using multiple imputation (13) . Outcome variables examined included days with severe hypoxemia (Pa O 2 /FI O 2 , 100), ventilator-free days through day 28, and in-hospital mortality.
Statistical Analysis
First, we compared demographics, comorbidities, risk factors, chest imaging findings, and outcomes across patients grouped by ARDS diagnosis (consensus-ARDS, disagreement, or no ARDS) using ANOVA for continuous variables, chi-square for categorical variables, and Poisson regression for days of severe hypoxemia or ventilator-free days. Patients were assigned to these groups based on their ARDS probability as described above. To determine whether differences were statistically significant, we used the Bonferroni correction to the P value, which lowers the P value threshold necessary to conclude that a result is statistically significant based on the number of comparisons performed to minimize false discovery (14) . A P value of 0.05/3 was considered significant because three comparisons were performed across groups.
Second, to understand whether the degree of hypoxemia was a surrogate for ARDS diagnosis, we performed a cross-tabulation of patients grouped by ARDS diagnosis (consensus-ARDS, disagreement, or no ARDS) and categories of hypoxemia (mild: .200; moderate: 100-200; severe: , 100) and examined the overlap between these two methods of categorizing patients. We compared mortality rates across ARDS diagnosis and hypoxemia categories, and calculated the mortality discrimination of each. Mortality discrimination was compared using the area under the receiver operating characteristic curve (AUC).
Third, we compared measures of lung injury severity (Pa O 2 /FI O 2 , plateau pressure, lung compliance, and dead space fraction) among patients grouped by ARDS diagnosis (consensus-ARDS, disagreement, or no ARDS). We generated area plots to illustrate the proportion of patients in each group over ranges of each physiologic measure. These plots were generated by first fitting a multinomial logistic regression model, where the ARDS diagnosis category (consensus-ARDS, disagreement, or no ARDS) was the outcome and the physiologic measure was the sole predictor. Restricted cubic splines with three knots were used to model potential nonlinear relationships between the predictor and outcome. After each model was fitted, the proportion of patients in each group was estimated across ranges of values for each physiologic measure.
Fourth Finally, we derived simple decision rules that could be used at the bedside to approximate the collective judgment of multiple clinicians and identify patients with agreement or disagreement about the diagnosis of ARDS. We derived rules using the ARDS risk factors pneumonia and shock, and the most common measure of lung injury severity (Pa O 2 /FI O 2 ratio). For this analysis, patients were again analyzed based on ARDS diagnosis categories (consensus-ARDS, disagreement, no ARDS). Decision rules were derived using a classification and regression tree, which attempts to find rules that split the data into subsets that maximize the purity of each subset, i.e., maximizing the number of patients in one group while minimizing the number of those from other groups. Gini impurity was used to derive the best splits. The decision rule's performance was evaluating using the AUC, and its generalization performance was estimated by drawing 1,000 bootstrap samples of the data to determine 95% confidence intervals.
All analyses were performed in Stata 14.0 and Python 3.6. The institutional review board of the University of Michigan approved this study with a wavier of informed consent from study participants.
Results
The cohort included 738 patients with a Pa O 2 /FI O 2 , 300 during invasive mechanical ventilation reviewed by multiple clinicians, with 1,863 total reviews performed. Among these patients, 110 (14.9%) had consensus-ARDS, 100 had disagreement about the diagnosis (13.6%), and 528 did not have ARDS (71.5%) ( Table 1 ). There was notable variation among the 13 clinicians in ARDS diagnosis rates, ranging from 8% to 47% ( Figure E1 in the online supplement), although diagnostic agreement rates among clinicians ranged from 69% to 83%, and only 7% of the overall variation in ARDS diagnosis was attributable to clinicians rather than patients. ARDS diagnosis rates were 20% among fellows (n = 7), 30% among clinical faculty (n = 3), and 34% among faculty involved in ARDS clinical trials (n = 3), although these results were not statistically different (Table E1) .
On hospital presentation, patients with disagreement about the diagnosis of ARDS had no significant differences in comorbidities that could potentially mask or confuse the diagnosis, including rates of obesity, congestive heart failure, and chronic kidney disease (Table 1 ). However, rates of specific ARDS risk factors were significantly different across groups. Pneumonia was present in 75% of patients with consensus-ARDS, 49% of patients with disagreement, and 19% of patients without ARDS (significantly different across pairwise comparisons; see Table E2 for P values). Noncardiogenic shock was present in 62% of patients with consensus-ARDS, 43% of patients with disagreement, and 23% of patients without ARDS, and also significantly different across groups. Rates of nonpulmonary sepsis were higher in patients with consensus-ARDS (35%) or disagreement (32%) than in patients without ARDS (17%), but not significantly different between patients with consensus-ARDS and disagreement.
Chest imaging studies more clearly demonstrated bilateral airspace disease in patients with consensus-ARDS compared with other groups (Table 1) : 70% of the chest imaging studies showed bilateral airspace disease in patients with consensus-ARDS, 23% showed bilateral airspace disease in patients with disagreement, and 8% showed bilateral airspace disease in patients without ARDS. There was no difference in the rates of chest computed tomography scans across groups.
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Clinical outcomes, including days with severe hypoxemia, ventilator-free days, and mortality, were different across groups, but only days with severe hypoxemia and ventilator-free days were statistically significantly different across all pairwise comparisons. Mean days of severe hypoxemia were 3.2 (95% CI, 2.6-3.9), 2.0 (95% CI, 1.5-2.4), and 0.8 (95% CI, 0.7-0.9) among patients with consensus-ARDS, disagreement, and no ARDS, respectively. Hospital mortality was 37% (95% CI, 28-46%), 35% (95% CI, 26-44%), and 19% (95% CI, 15-22%) across groups.
There was minimal concordance between a patient's degree of hypoxemia and the diagnosis of ARDS ( Neither the ARDS diagnosis categories nor the hypoxemia categories provided good discrimination of mortality (AUC = 0.60 and 0.59, respectively; Figures E2 and E3) .
Physiologic parameters during the first 24 hours after ARDS onset and matched periods during mechanical ventilation for patients without ARDS revealed that patients with consensus-ARDS had worse lung injury than other patients (Figure 1) . However, there were no clear cutoff values that could distinguish patients with consensus-ARDS from patients without ARDS. For example, when the dead space fraction was above 80%, 26% of the patients had consensus-ARDS and 58% did not have ARDS.
The relationship between the Pa O 2 /FI O 2 ratio and ARDS diagnosis was significantly modified based on the presence or absence of the ARDS risk factors pneumonia and shock (Figure 2 ). Accounting for this interaction yielded an ARDS model with good discrimination (AUC = 0.84) and reasonable calibration across ARDS risk deciles ( Figure E4 ). In the setting of pneumonia and shock, the likelihood of ARDS diagnosis increased rapidly as Pa O 2 / FI O 2 worsened. However, when pneumonia or shock was absent, the strength of the relationship between Pa O 2 /FI O 2 and ARDS diagnosis was minimal.
Simple decision rules derived using the two most common ARDS risk factors and Pa O 2 /FI O 2 (Table 3) 
Discussion
In the current study, we found a high prevalence of patients with disagreement about the diagnosis of ARDS among those with hypoxemic respiratory failure. Patients with diagnostic disagreement appeared to be more borderline cases, with intermediate rates of common ARDS risk factors and measurements of lung injury severity. Yet, there were no clear cutoff values among single physiologic parameters (e.g., Pa O 2 / FI O 2 ) that could distinguish patients in any one group. We also found significant variation in the rate of ARDS diagnosis across clinicians: in half of the patients who received a diagnosis of ARDS from some clinicians, there was disagreement. Overall, these results suggest that differences in how clinicians dichotomize patients along a continuous spectrum of ARDS manifestations are an important driver of disagreement about the diagnosis. This analysis may have practical implications for how the diagnosis of ARDS can be improved in clinical practice. Given concerns that the low reliability of chest X-ray interpretation is a major driver of the low reliability of ARDS diagnosis (4, 16) , and that standardized training in chest imaging interpretation does not improve the reliability of chest X-ray interpretation (17) , the current analysis identified other important clinical characteristics that can help guide ARDS diagnosis. Specific combinations of clinical features can either strongly support the diagnosis of ARDS or potentially prompt physicians to perform further evaluation in patients in whom the diagnosis is likely to be unclear. The specific combination of pneumonia, shock, and severe hypoxemia strongly indicated ARDS. The diagnosis was less clear in patients with pneumonia and Pa O 2 /FI O 2 , 120 but no shock, and patients with shock and Pa O 2 / FI O 2 , 110 but without pneumonia. Patients without pneumonia or shock and with a Pa O 2 /FI O 2 . 180 uniformly did not have ARDS, although these criteria should be validated in additional populations.
The finding in this study that patients with pneumonia and shock were most likely to receive a diagnosis of ARDS by a consensus of physicians aligns with the current understanding of the pathophysiology of this syndrome. In contrast to previous research that attempted to place patients in mutually exclusive categories of pulmonary and nonpulmonary ARDS (18, 19) , we found that patients with risk factors from both groups had the highest rate of consensus-ARDS. 
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Inflammatory fluid filling the alveoli during ARDS may arise after injury to both the lung epithelium and endothelium (20) . Injury to one without the other fails to cause clear manifestations of ARDS in a classic sheep model of this syndrome (21) . Patients presenting with pneumonia and shock may have both direct lung epithelial injury and indirect endothelial injury from the systemic inflammatory response, leading to the more unambiguous manifestations of ARDS.
The current analysis suggests that rather than being a deterministic phenomenon, patients with features of ARDS have a spectrum of clinical manifestations and severity. Differences in where physicians choose to dichotomize patients along this spectrum seemed to be a primary driver of disagreement. Considering ARDS as a spectrum of clinical manifestations-in the same way that acute kidney injury is a spectrum-may be useful when examining the strength of associations with ARDS risk factors or the heterogeneity of treatment effects on outcomes in patients with ARDS. For example, in a study by Shah and colleagues, excluding patients in whom it was difficult to establish a diagnosis because they lacked clear manifestations of ARDS led to findings of stronger associations between molecular markers and ARDS development (22) . Rather than excluding such patients, an alternative approach used in recent study aiming to develop an algorithm to diagnosis ARDS weighted patients used to train the algorithm based on the clinical reviewer's confidence in the diagnosis (23) . For example, if patients exhibited clear manifestations of ARDS, their diagnoses were assigned higher confidence, and these patients were weighted more heavily in the algorithm.
Although the current Berlin definition does conceptualize ARDS as having a (24) and enable better tailoring of treatments in clinical practice. Our study has some limitations. Because one of our interests was in understanding differences in the degree of lung injury across patient groups, we focused on patients receiving mechanical ventilation, enabling the calculation of lung compliance or the dead space fraction. With the increasing use of high-flow nasal cannula, more patients with manifestations of ARDS may not receive mechanical ventilation. We suspect our findings would also apply to this population, but this requires confirmation. Additionally, the analysis was performed using data recorded in the electronic health record as part of routine care. Such data may have a higher level of error rates than prospectively collected research data, which may have blunted any differences between patient groups (6). Diagnostic agreement was evaluated among clinicians who reviewed patients retrospectively, so whether similar results would be obtained from a prospective evaluation is not known. Finally, although our study included 13 critical-care physicians and a large cohort of patients drawn from medical, surgical, cardiac, and trauma patient populations, further validation of the findings in additional patient cohorts is warranted.
Conclusions
Patients with disagreement about the diagnosis of ARDS had more intermediate rates of ARDS risk factors and lung injury severity. Overall, these findings suggest that ARDS has a spectrum of clinical manifestations, and the difficulty of dichotomizing patients along this spectrum may explain disagreements about the diagnosis of ARDS. Considering both the presence of key ARDS risk factors and hypoxemia severity can help guide clinicians in identifying patients with a diagnosis of ARDS agreed upon by a consensus of physicians. n
